Chemistry Wealth Management’s Invesco S&P 500 Equal Weight ETF RSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.25M Buy
5,858
+6
+0.1% +$1.23K 0.2% 77
2026
Q1
$1.12M Sell
5,852
-91
-2% -$18K 0.2% 74
2025
Q4
$1.14M Hold
5,943
0.21% 75
2025
Q3
$1.13M Buy
5,943
+188
+3% +$35K 0.22% 73
2025
Q2
$1.05M Hold
5,755
0.22% 72
2025
Q1
$997K Buy
5,755
+206
+4% +$36.6K 0.23% 70
2024
Q4
$972K Hold
5,549
0.23% 70
2024
Q3
$994K Buy
5,549
+78
+1% +$13.3K 0.24% 68
2024
Q2
$899K Buy
5,471
+148
+3% +$24.3K 0.23% 69
2024
Q1
$902K Buy
5,323
+150
+3% +$24.1K 0.24% 71
2023
Q4
$816K Hold
5,173
0.25% 70
2023
Q3
$733K Hold
5,173
0.24% 69
2023
Q2
$774K Buy
5,173
+71
+1% +$10.2K 0.25% 67
2023
Q1
$738K Hold
5,102
0.26% 66
2022
Q4
$721K Hold
5,102
0.28% 62
2022
Q3
$649K Hold
5,102
0.26% 65
2022
Q2
$685K Hold
5,102
0.26% 68
2022
Q1
$805K Buy
+5,102
New +$796K 0.28% 58

Other funds holding RSP

Chemistry Wealth Management's RSP Position: Q2 2026 in Review

Chemistry Wealth Management increased its Invesco S&P 500 Equal Weight ETF (RSP) stake by 0.1% in Q2 2026, buying an estimated $1.23K and bringing the position to 5,858 shares worth $1.25M. The position accounts for 0.2% of the portfolio, ranked #77.

Chemistry Wealth Management first reported a position in RSP in Q1 2022 and has held it in 18 quarters since. 1,221 funds tracked by Wall St. Rank hold RSP as of Q2 2026.

  • Chemistry Wealth Management held 5,858 shares of Invesco S&P 500 Equal Weight ETF worth $1.25M as of Q2 2026.
  • Chemistry Wealth Management bought 6 Invesco S&P 500 Equal Weight ETF shares in Q2 2026, an estimated $1.23K.
  • Invesco S&P 500 Equal Weight ETF made up 0.2% of Chemistry Wealth Management's portfolio in Q2 2026, its #77 holding.
  • Chemistry Wealth Management first reported a position in Invesco S&P 500 Equal Weight ETF in Q1 2022 and has held it in 18 quarters since.
  • 1,221 funds tracked by Wall St. Rank held Invesco S&P 500 Equal Weight ETF as of Q2 2026.

Based on Chemistry Wealth Management's 13F filing for Q2 2026, filed 9 Jul 2026.